Presented by Gustave Roussy and SOCRATE, in collaboration with the Society for Immunotherapy of Cancer
Accreditation Statement
The Primer on Immunology and Cancer Immunotherapy, Paris, France, 20/09/2018-20/09/2018 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 3 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for UNION EUROPÉENNE DES MÉDECINS SPÉCIALISTES EUROPEAN UNION OF MEDICAL SPECIALISTS Association internationale sans but lucratif – International non-profit organisation
Avenue de la Couronne, 20 T +32 2 649 51 64
BE- 1050 BRUSSELS F +32 2 640 37 30
www.uems.net info@uems.net
ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
Session Agenda The Primer on Cancer Immunology and Immunotherapy will be held on September 20, 2018 and is part of the International Conference on Immunotherapy Radiotherapy Combinations from September 20 – 22, 2018.
|
8:15 – 8:30 a.m.
|
Welcome and Introduction
Alexander Eggermont, MD, PhD and Eric Duetsch, MD, PhD
|
|
Session I: Immunology from the basics to the clinic
|
|
8:30 – 9:00 a.m.
|
Innate Immunity
Vincenzo Bronte, MD* – University of Verona
|
|
9:00 – 9:30 a.m.
|
Adaptive Immunity
Anna Mondino, PhD – San Raffaele Scientific Institute
|
|
9:30 – 10:00 a.m.
|
State of the art clinical immunology: the melanoma revolution (provisional title)
Alexander Eggermont, MD, PhD – GRCC, Villejuif
|
|
10:00 – 10:30 a.m.
|
Coffee Break
|
|
Session II: Immunotherapy from bend to bedside
|
|
10:30 – 11:15 a.m.
|
Keynote METABOLISM
Calorie restriction mimetics as cancer therapy (provisional title)
Guido Kroemer, MD, PhD – CRC, Paris
|
|
11:15 – 11:45 a.m.
|
Autophagy and immunological cell death
Lorenzo Galluzzi, PhD* – WCM, New York
|
|
11:45 a.m. – 12:15 p.m.
|
Immuno-score (provisional title)
JérômeGalon, PhD* – CRC, Paris
|
|
12:15 – 12:45 p.m.
|
Clinical immune-oncology
Aurélien Marabelle, MD, PhD – GRCC, Villejuif
|
*SITC Member
Attention SITC members! Take advantage of discounted rates! For more information, click here.
View the SITC Meeting Code of Conduct.
#Immunoscore
#ClinicalTrials
#Collaboration
#Oncologist
#2018
#Biomarkers
#LungCancers
#HematologicMalignancies
#Small-Cell Lung Cancer
#CombinationTherapy
#ImmuneResponsiveness